Skip to main content
. 2022 Feb 17;9:843512. doi: 10.3389/fnut.2022.843512

Table 2.

Baseline demographics details and questionnaire scores.

Placebo (n = 45) Lutein/zeaxanthin (n = 45) p-value
Age Mean 60.04 58.78 0.480a
SE 1.27 1.26
Sex Female (n) 35 36 0.796b
Male (n) 10 9
BMI Mean 27.12 27.20 0.934a
SE 0.59 0.67
Systolic blood pressure (mmHg) Mean 126.60 128.89 0.501a
SE 2.29 2.50
Diastolic blood pressure (mmHg) Mean 82.58 82.89 0.866a
SE 1.17 1.42
Marital status Single 18 11 0.114b
Married/ defacto 27 34
Educational level Secondary 20 16 0.435b
Tertiary 17 16
Post-graduate 8 13
Exercise level (n) Never/ rarely 8 7 0.519b
1 to 2 times a week 5 10
3 to 5 times a week 15 15
6+ times a week 17 13
Taking any prescription medication Yes 21 26 0.291b
Taking nutraceutical/ phytoceutical Yes 25 21 0.399b
TICS score Mean 26.87 27.40 0.461a
SE 0.56 0.46
CFQ - Total score Mean 43.16 43.33 0.946a
SE 1.57 2.10
BRIEF-A Behavioral Regulation Mean 45.42 44.78 0.735a
SE 1.21 1.46
BRIEF-A Metacognition Mean 66.84 65.87 0.728a
SE 1.91 2.05
PROMIS-29 Physical Function Mean 18.98 19.18 0.593a
SE 0.28 0.25
PROMIS-29 Anxiety Mean 7.11 7.40 0.756a
SE 0.83 0.41
PROMIS-29 Depression Mean 6.07 6.44 0.503a
SE 0.42 0.38
PROMIS-29 Fatigue Mean 10.40 10.02 0.648a
SE 0.58 0.59
PROMIS-29 Sleep disturbances Mean 11.58 10.56 0.174a
SE 0.60 0.45
PROMIS-29 Ability to participate in social roles and activities Mean 16.18 16.16 0.977a
SE 0.57 0.54
PROMIS-29 Pain interference Mean 6.84 6.29 0.439a
SE 0.556 0.45
PROMIS-29 Pain intensity Mean 2.38 1.84 0.203a
SE 0.32 0.266
POMS-A Total Mood Disturbance Mean 90.69 91.02 0.914a
SE 1.84 2.46
a

Independent samples t-test;

b

Chi-square analysis.